TREATMENT READING
Childhood Acute Myeloid Leukemia
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
24 studies cited in this topic · see design and results →
Explore 3 related disease and treatment settings → · Source-derived catalogue; clinical review pending.
AML or MDS may occur after treatment with certain chemotherapy drugs and/or radiation therapy.
Certain factors affect prognosis (chance of recovery) and treatment options.
Sometimes childhood acute myeloid leukemia and other myeloid malignancies do not respond to treatment or come back after treatment.
Treatment Option Overview
Key Points
There are different types of treatment for children with acute myeloid leukemia and other myeloid malignancies.
Treatment is planned by a team of health care providers who are experts in treating childhood leukemia and other diseases of the blood.
The treatment of childhood AML and other myeloid malignancies usually has two phases.
Seven types of standard treatment may be used for childhood AML and other myeloid malignancies.
Chemotherapy
Radiation therapy
Stem cell transplant
Targeted therapy
Other drug therapy
Watchful waiting
Supportive care
New types of treatment are being tested in clinical trials.
Treatment for childhood acute myeloid leukemia and other myeloid malignancies may cause side effects.
Patients may want to think about taking part in a clinical trial.
Patients can enter clinical trials before, during, or after starting their cancer treatment.
Follow-up tests may be needed.
Treatment of Childhood Acute Myeloid Leukemia
Treatment of Transient Abnormal Myelopoiesis or Children with Down Syndrome and AML
Treatment of Childhood Acute Promyelocytic Leukemia
Treatment of Juvenile Myelomonocytic Leukemia
Treatment of Childhood Chronic Myelogenous Leukemia
Treatment of Childhood Myelodysplastic Syndromes
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle